Literature DB >> 30881736

Distal Rectus Femoris Tendon Transfer for the Correction of Stiff-Knee Gait in Cerebral Palsy.

T Dreher1, F Braatz1, S I Wolf1, V Ewerbeck1, D Heitzmann1, W Wenz1, L Döderlein2.   

Abstract

INTRODUCTION: Distal rectus femoris tendon transfer is the standard surgical procedure for the treatment of stiff-knee gait in patients with cerebral palsy and is commonly performed during single-event multilevel surgery. STEP 1 POSITIONING AND APPROACH: With the patient supine, make a 3 to 4-cm longitudinal incision 2 to 3 cm above the patellar proximal pole. STEP 2 PREPARATION OF THE RECTUS FEMORIS TENDON: Separate the rectus femoris tendon from the vasti; avoid releasing the entire quadriceps at all cost. STEP 3 PREPARATION OF THE GRACILIS OR SEMITENDINOSUS TENDON FOR TRANSFER: Isolate the gracilis tendon proximally, release it from its muscle belly, and pull it out distally through a small incision at the pes anserinus insertion. STEP 4 TRANSFERRING THE GRACILIS TENDON TO THE RECTUS FEMORIS TENDON: Insert a long tendon passer above the fascia and beneath the sartorius muscle belly from anterior to posterior to the mini-incision in the pes anserinus region to grasp and transfer the gracilis tendon to the anterior approach. STEP 5 TENDON TENSIONING AND SUTURING: Weave the gracilis tendon into the released rectus femoris tendon with the interlacing technique described by Pulvertaft.
RESULTS: Various studies have demonstrated good initial results, with an improvement in peak knee flexion in swing phase and knee motion in swing phase, following distal rectus femoris tendon transfer. WHAT TO WATCH FOR: IndicationsContraindicationsPitfalls & Challenges.

Entities:  

Year:  2013        PMID: 30881736      PMCID: PMC6407945          DOI: 10.2106/JBJS.ST.L.00030

Source DB:  PubMed          Journal:  JBJS Essent Surg Tech        ISSN: 2160-2204


  27 in total

Review 1.  Coordination of two- and one-joint muscles: functional consequences and implications for motor control.

Authors:  B I Prilutsky
Journal:  Motor Control       Date:  2000-01       Impact factor: 1.422

2.  Magnetic resonance imaging findings after rectus femoris transfer surgery.

Authors:  Garry E Gold; Deanna S Asakawa; Silvia S Blemker; Scott L Delp
Journal:  Skeletal Radiol       Date:  2003-11-06       Impact factor: 2.199

3.  In vivo motion of the rectus femoris muscle after tendon transfer surgery.

Authors:  Deanna S Asakawa; Silvia S Blemker; Garry E Gold; Scott L Delp
Journal:  J Biomech       Date:  2002-08       Impact factor: 2.712

4.  SUTURE MATERIALS AND TENDON JUNCTURES.

Authors:  R G PULVERTAFT
Journal:  Am J Surg       Date:  1965-03       Impact factor: 2.565

5.  Outcome of hamstring lengthening and distal rectus femoris transfer surgery.

Authors:  S Rethlefsen; V T Tolo; R A Reynolds; R Kay
Journal:  J Pediatr Orthop B       Date:  1999-04       Impact factor: 1.041

6.  Propulsive function during gait in diplegic children: evaluation after surgery for gait improvement.

Authors:  E B Zwick; V Saraph; W E Linhart; G Steinwender
Journal:  J Pediatr Orthop B       Date:  2001-07       Impact factor: 1.041

7.  Rectus femoris release in selected patients with cerebral palsy: a preliminary report.

Authors:  D H Sutherland; L J Larsen; R Mann
Journal:  Dev Med Child Neurol       Date:  1975-02       Impact factor: 5.449

8.  Predictive value of the Duncan-Ely test in distal rectus femoris transfer.

Authors:  Robert M Kay; Susan A Rethlefsen; John P Kelly; Tishya A L Wren
Journal:  J Pediatr Orthop       Date:  2004 Jan-Feb       Impact factor: 2.324

9.  Rectus femoris transfer for children with cerebral palsy: long-term outcome.

Authors:  Aik Saw; Peter A Smith; Yuddhasert Sirirungruangsarn; Shande Chen; Sahar Hassani; Gerald Harris; Ken N Kuo
Journal:  J Pediatr Orthop       Date:  2003 Sep-Oct       Impact factor: 2.324

10.  Clinical utility of the Duncan-Ely test for rectus femoris dysfunction during the swing phase of gait.

Authors:  M C Marks; J Alexander; D H Sutherland; H G Chambers
Journal:  Dev Med Child Neurol       Date:  2003-11       Impact factor: 5.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.